SFS announces new management responsibility for the Medical division

News – 27 May 2020

J. Mark King decided to retire and resign as Head of the Medical division. Until nomination of a successor, Jens Breu, CEO of the SFS Group, will temporarily assume responsibility for the Medical division. Strengthening the position in the MedTech industry is a key priority for the SFS Group and will be supported by substantial investments in employees and capacities.

After almost 10 years of service as the CEO of Tegra Medical and as Head of Medical division within the SFS Group, J. Mark King decided to retire as of 1 August 2020. The Board of Directors and the Group Executive Board thank J. Mark King for his many years of services.

The MedTech industry is an important market segment for the SFS Group. It is the strategic goal to further strengthen and to grow SFS' position in the MedTech market. Substantial investments to support the initiated growth project are planned in order to pursue this goal.

Until the nomination of successor, Jens Breu, CEO of the SFS Group, will assume temporarily the responsibility for the Medical division.